{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:11:21Z","timestamp":1791465081567,"version":"4.3.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T00:00:00Z","timestamp":1712793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>COVID-19-associated pulmonary aspergillosis (CAPA) is burdened by high mortality. Data are lacking about non-ICU patients. Aims of this study were to: (i) assess the incidence and prevalence of CAPA in a respiratory sub-intensive care unit, (ii) evaluate its risk factors and (iii) impact on in-hospital mortality. Secondary aims were to: (i) assess factors associated to mortality, and (ii) evaluate significant features in hematological patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>This was a single-center, retrospective study of COVID-19 patients with acute respiratory failure. A cohort of CAPA patients was compared to a non-CAPA cohort. Among patients with CAPA, a cohort of hematological patients was further compared to another of non-hematological patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Three hundred fifty patients were included in the study. Median P\/F ratio at the admission to sub-intensive unit was 225\u00a0mmHg (IQR 155\u2013314). 55 (15.7%) developed CAPA (incidence of 5.5%). Eighteen had probable CAPA (37.3%), 37 (67.3%) possible CAPA and none proven CAPA. Diagnosis of CAPA occurred at a median of 17\u00a0days (IQR 12\u201331) from SARS-CoV-2 infection. Independent risk factors for CAPA were hematological malignancy [OR 1.74 (95%CI 0.75\u20134.37), <jats:italic>p<\/jats:italic>\u2009=\u20090.0003], lymphocytopenia [OR 2.29 (95%CI 1.12\u20134.86), <jats:italic>p<\/jats:italic>\u2009=\u20090.02], and COPD [OR 2.74 (95%CI 1.19\u20135.08), <jats:italic>p<\/jats:italic>\u2009=\u20090.014]. Mortality rate was higher in CAPA cohort (61.8% vs 22.7%, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). CAPA resulted an independent risk factor for in-hospital mortality [OR 2.92 (95%CI 1.47\u20135.89), <jats:italic>p<\/jats:italic>\u2009=\u20090.0024]. Among CAPA patients, age\u2009&gt;\u200965\u00a0years resulted a predictor of mortality [OR 5.09 (95% CI 1.20\u201326.92), <jats:italic>p<\/jats:italic>\u2009=\u20090.035]. No differences were observed in hematological cohort.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CAPA is a life-threatening condition with high mortality rates. It should be promptly suspected, especially in case of hematological malignancy, COPD and lymphocytopenia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-024-09283-3","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T11:01:59Z","timestamp":1712833319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit"],"prefix":"10.1186","volume":"24","author":[{"given":"Alessandra","family":"Iacovelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Oliva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio Marco","family":"Mirabelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Giannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Laguardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Morviducci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Nicolardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Repaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Teresa","family":"Sanzari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Leanza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giammarco","family":"Raponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Palange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,11]]},"reference":[{"issue":"6","key":"9283_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.3201\/eid1606.100165","volume":"16","author":"A Lat","year":"2010","unstructured":"Lat A, Bhadelia N, Miko B, et al. Invasive aspergillosis after pandemic (H1N1) 2009. Emerg Infect Dis. 2010;16(6):971\u20133. https:\/\/doi.org\/10.3201\/eid1606.100165.","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"9283_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.diagmicrobio.2018.01.014","volume":"91","author":"MM Shah","year":"2018","unstructured":"Shah MM, Hsiao EI, Kirsch CM, et al. Invasive pulmonary aspergillosis and influenza co-infection in immunocompetent hosts: case reports and review of the literature. Diagn Microbiol Infect Dis. 2018;91(2):147\u201352. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2018.01.014.","journal-title":"Diagn Microbiol Infect Dis."},{"issue":"2","key":"9283_CR3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/2049-632X.12166","volume":"71","author":"S Milne-Price","year":"2014","unstructured":"Milne-Price S, Miazgowicz KL, Munster VJ. The emergence of the Middle East respiratory syndrome coronavirus. Pathog Dis. 2014;71(2):121\u201336. https:\/\/doi.org\/10.1111\/2049-632X.12166.","journal-title":"Pathog Dis."},{"issue":"8","key":"9283_CR4","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","volume":"47","author":"PE Verweij","year":"2021","unstructured":"Verweij PE, Br\u00fcggemann RJM, Azoulay E, et al. Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis. Intensive Care Med. 2021;47(8):819\u201334. https:\/\/doi.org\/10.1007\/s00134-021-06449-4.","journal-title":"Intensive Care Med"},{"issue":"6","key":"9283_CR5","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S1473-3099(20)30847-1","volume":"21","author":"P Koehler","year":"2021","unstructured":"Koehler P, Bassetti M, Chakrabarti A, European Confederation of Medical Mycology, International Society for Human Animal Mycology, Asia Fungal Working Group, INFOCUS LATAM\/ISHAM Working Group, ISHAM Pan Africa Mycology Working Group, European Society for Clinical Microbiology, Infectious Diseases Fungal Infection Study Group, ESCMID Study Group for Infections in Critically Ill Patients, Interregional Association of Clinical Microbiology and Antimicrobial Chemotherapy, Medical Mycology Society of Nigeria, Medical Mycology Society of China Medicine Education Association, Infectious Diseases Working Party of the German Society for Haematology and Medical Oncology, Association of Medical Microbiology, Infectious Disease Canada, et al. Lancet Infect Dis. 2021;21(6):149\u201362. https:\/\/doi.org\/10.1016\/S1473-3099(20)30847-1.","journal-title":"Lancet Infect Dis"},{"issue":"9","key":"9283_CR6","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/myc.13292","volume":"64","author":"H Mitaka","year":"2021","unstructured":"Mitaka H, Kuno T, Takagi H, et al. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis. Mycoses. 2021;64(9):993\u20131001. https:\/\/doi.org\/10.1111\/myc.13292.","journal-title":"Mycoses"},{"issue":"4","key":"9283_CR7","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","volume":"28","author":"J Prattes","year":"2022","unstructured":"Prattes J, Wauters J, Giacobbe DR, et al. ECMM-CAPA Study Group. Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology. Clin Microbiol Infect. 2022;28(4):580\u20137. https:\/\/doi.org\/10.1016\/j.cmi.2021.08.014.","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"9283_CR8","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3201\/eid2704.204895","volume":"27","author":"J Salmanton-Garc\u00eda","year":"2021","unstructured":"Salmanton-Garc\u00eda J, Sprute R, Stemler J, et al. FungiScope European Confederation of Medical Mycology\/The International Society for Human and Animal Mycology Working Group. COVID-19-Associated Pulmonary Aspergillosis, March-August 2020. Emerg Infect Dis. 2021;27(4):1077\u201386. https:\/\/doi.org\/10.3201\/eid2704.204895.","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"9283_CR9","doi-asserted-by":"publisher","first-page":"e16982","DOI":"10.7759\/cureus.16982","volume":"13","author":"A Iqbal","year":"2021","unstructured":"Iqbal A, Ramzan M, Akhtar A, et al. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study. Cureus. 2021;13(8):e16982. https:\/\/doi.org\/10.7759\/cureus.16982.","journal-title":"Cureus"},{"issue":"3","key":"9283_CR10","doi-asserted-by":"publisher","first-page":"e0238825","DOI":"10.1371\/journal.pone.0238825","volume":"16","author":"T Lahmer","year":"2021","unstructured":"Lahmer T, Kriescher S, Herner A, et al. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: Results from the prospective AspCOVID-19 study. PLoS ONE. 2021;16(3):e0238825. https:\/\/doi.org\/10.1371\/journal.pone.0238825.","journal-title":"PLoS ONE"},{"issue":"6","key":"9283_CR11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.3390\/jof9060689","volume":"9","author":"A Beltrame","year":"2023","unstructured":"Beltrame A, Stevens DA, Haiduven D. Mortality in ICU Patients with COVID-19-Associated Pulmonary Aspergillosis. J Fungi (Basel). 2023;9(6):689. https:\/\/doi.org\/10.3390\/jof9060689.","journal-title":"J Fungi (Basel)."},{"issue":"5","key":"9283_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/myc.13434","volume":"65","author":"J Calder\u00f3n-Parra","year":"2022","unstructured":"Calder\u00f3n-Parra J, Mills-Sanchez P, Moreno-Torres V, HUPH IFI Study Group, et al. COVID-19-associated pulmonary aspergillosis (CAPA): Risk factors and development of a predictive score for critically ill COVID-19 patients. Mycoses. 2022;65(5):541\u201350. https:\/\/doi.org\/10.1111\/myc.13434.","journal-title":"Mycoses"},{"issue":"8","key":"9283_CR13","doi-asserted-by":"publisher","first-page":"753659","DOI":"10.3389\/fmed.2021.753659","volume":"16","author":"J Xu","year":"2021","unstructured":"Xu J, Yang X, Lv Z, et al. Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study. Front Med (Lausanne). 2021;16(8):753659. https:\/\/doi.org\/10.3389\/fmed.2021.753659.","journal-title":"Front Med (Lausanne)"},{"issue":"11","key":"9283_CR14","doi-asserted-by":"publisher","first-page":"e3606","DOI":"10.1093\/cid\/ciaa1065","volume":"73","author":"M Bartoletti","year":"2021","unstructured":"Bartoletti M, Pascale R, Cricca M, PREDICO Study Group, et al. Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study. Clin Infect Dis. 2021;73(11):e3606\u201314. https:\/\/doi.org\/10.1093\/cid\/ciaa1065.","journal-title":"Clin Infect Dis"},{"key":"9283_CR15","doi-asserted-by":"publisher","unstructured":"Hurt W, Youngs J, Ball J et al. COVID-19-associated pulmonary aspergillosis in mechanically ventilated patients: a prospective, multicentre UK study. Thorax. 2023 Sep 1:thorax-2023\u2013220002. https:\/\/doi.org\/10.1136\/thorax-2023-220002.","DOI":"10.1136\/thorax-2023-220002"},{"issue":"1","key":"9283_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s15010-021-01701-x","volume":"50","author":"WH Chong","year":"2022","unstructured":"Chong WH, Saha BK, Neu KP. Comparing the clinical characteristics and outcomes of COVID-19-associate pulmonary aspergillosis (CAPA): a systematic review and meta-analysis. Infection. 2022;50(1):43\u201356. https:\/\/doi.org\/10.1007\/s15010-021-01701-x.","journal-title":"Infection"},{"key":"9283_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.clinimag.2022.07.003","volume":"90","author":"W Hong","year":"2022","unstructured":"Hong W, White PL, Backx M, et al. CT findings of COVID-19-associated pulmonary aspergillosis: a systematic review and individual patient data analysis. Clin Imaging. 2022;90:11\u20138. https:\/\/doi.org\/10.1016\/j.clinimag.2022.07.003.","journal-title":"Clin Imaging"},{"issue":"5","key":"9283_CR18","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/diagnostics12051201","volume":"12","author":"T Fischer","year":"2022","unstructured":"Fischer T, El Baz Y, Graf N, et al. Clinical and Imaging Features of COVID-19-Associated Pulmonary Aspergillosis. Diagnostics (Basel). 2022;12(5):1201. https:\/\/doi.org\/10.3390\/diagnostics12051201.","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"9283_CR19","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1177\/08850666211047166","volume":"37","author":"Z Hashim","year":"2022","unstructured":"Hashim Z, Neyaz Z, Marak RSK, et al. Practice Guidelines for the Diagnosis of COVID-19-Associated Pulmonary Aspergillosis in an Intensive Care Setting. J Intensive Care Med. 2022;37(8):985\u201397. https:\/\/doi.org\/10.1177\/08850666211047166.","journal-title":"J Intensive Care Med"},{"issue":"7","key":"9283_CR20","doi-asserted-by":"publisher","first-page":"e1634","DOI":"10.1093\/cid\/ciaa1298","volume":"73","author":"PL White","year":"2021","unstructured":"White PL, Dhillon R, Cordey A, et al. A National Strategy to Diagnose Coronavirus Disease 2019-Associated Invasive Fungal Disease in the Intensive Care Unit. Clin Infect Dis. 2021;73(7):e1634\u201344. https:\/\/doi.org\/10.1093\/cid\/ciaa1298.","journal-title":"Clin Infect Dis"},{"issue":"23","key":"9283_CR21","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1001\/jama.2012.5669","volume":"307","author":"VM Ranieri","year":"2012","unstructured":"ARDS Definition Task Force, Ranieri VM, Rubenfeld GD, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526\u201333. https:\/\/doi.org\/10.1001\/jama.2012.5669.","journal-title":"JAMA"},{"key":"9283_CR22","unstructured":"WHO. Clinical management of COVID-19. World Health Organization. Interim guidance 27 May, 2020. https:\/\/www.who.int\/publications-detail\/clinical-management-of-covid-19. Date last updated: 23 Nov 2021. Date last accessed: 2 Jan 2024."},{"key":"9283_CR23","unstructured":"WHO. Clinical care of severe acute respiratory infections. https:\/\/www.who.int\/publications\/i\/item\/clinical-care-of-severe-acute-respiratory-infections-tool-kit. Date last updated: 6 Apr 2022. Date last accessed: 2 Jan 2024."},{"issue":"6","key":"9283_CR24","doi-asserted-by":"publisher","first-page":"2275","DOI":"10.1007\/s10238-023-01027-y","volume":"23","author":"A Oliva","year":"2023","unstructured":"Oliva A, CogliatiDezza F, Petrucci F, et al. Outcome of COVID-19 patients with haematological malignancies after the introduction of vaccination and monoclonal antibodies: results from the HM-COV 2 0 study. Clin Exp Med. 2023;23(6):2275\u201385. https:\/\/doi.org\/10.1007\/s10238-023-01027-y.","journal-title":"Clin Exp Med."},{"issue":"5","key":"9283_CR25","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s15010-021-01624-7","volume":"49","author":"A Oliva","year":"2021","unstructured":"Oliva A, Ceccarelli G, Borrazzo C, et al. Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission. Infection. 2021;49(5):965\u201375. https:\/\/doi.org\/10.1007\/s15010-021-01624-7.","journal-title":"Infection."},{"issue":"8","key":"9283_CR26","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1056\/NEJMoa2021436","volume":"384","author":"P Horby","year":"2021","unstructured":"Recovery Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384(8):693\u2013704. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"},{"issue":"11","key":"9283_CR27","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1111\/myc.13485","volume":"65","author":"Z Hashim","year":"2022","unstructured":"Hashim Z, Nath A, Khan A, et al. New insights into development and mortality of COVID-19-associated pulmonary aspergillosis in a homogenous cohort of 1161 intensive care patients. Mycoses. 2022;65(11):1010\u201323. https:\/\/doi.org\/10.1111\/myc.13485.","journal-title":"Mycoses"},{"issue":"4","key":"9283_CR28","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1182\/blood-2002-05-1496","volume":"63","author":"TF Patterson","year":"2016","unstructured":"Patterson TF, Thompson GR 3rd, Denning DW, et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2016;63(4):e1\u201360. https:\/\/doi.org\/10.1182\/blood-2002-05-1496.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"9283_CR29","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1183\/09031936.00062206","volume":"30","author":"P Bulpa","year":"2007","unstructured":"Bulpa P, Dive A, Sibille Y. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease. Eur Respir J. 2007;30(4):782\u2013800. https:\/\/doi.org\/10.1183\/09031936.00062206.","journal-title":"Eur Respir J"},{"issue":"1","key":"9283_CR30","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00094-21","volume":"35","author":"F Salazar","year":"2022","unstructured":"Salazar F, Bignell E, Brown GD, et al. Pathogenesis of Respiratory Viral and Fungal Coinfections. Clin Microbiol Rev. 2022;35(1): e0009421. https:\/\/doi.org\/10.1128\/CMR.00094-21.","journal-title":"Clin Microbiol Rev"},{"issue":"11","key":"9283_CR31","doi-asserted-by":"publisher","first-page":"ofab478","DOI":"10.1093\/ofid\/ofab478","volume":"8","author":"A Apostolopoulou","year":"2021","unstructured":"Apostolopoulou A, Clancy CJ, Skeel A, et al. Invasive Pulmonary Aspergillosis Complicating Noninfluenza Respiratory Viral Infections in Solid Organ Transplant Recipients. Open Forum Infect Dis. 2021;8(11):ofab478. https:\/\/doi.org\/10.1093\/ofid\/ofab478.","journal-title":"Open Forum Infect Dis."},{"issue":"2","key":"9283_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.jointm.2021.07.001","volume":"1","author":"G Dimopoulos","year":"2021","unstructured":"Dimopoulos G, Almyroudi MP, Myrianthefs P, et al. COVID-19-Associated Pulmonary Aspergillosis (CAPA). J Intensive Med. 2021;1(2):71\u201380. https:\/\/doi.org\/10.1016\/j.jointm.2021.07.001.","journal-title":"J Intensive Med"},{"issue":"4","key":"9283_CR33","doi-asserted-by":"publisher","first-page":"75","DOI":"10.18502\/cmm.6.4.5442","volume":"6","author":"M Tavakoli","year":"2020","unstructured":"Tavakoli M, Shokohi T, Lass Fl\u00f6rl C, et al. Immunological response to COVID-19 and its role as a predisposing factor in invasive aspergillosis. Curr Med Mycol. 2020;6(4):75\u20139. https:\/\/doi.org\/10.18502\/cmm.6.4.5442.","journal-title":"Curr Med Mycol"},{"issue":"5","key":"9283_CR34","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"G Chen","year":"2020","unstructured":"Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130(5):2620\u20139. https:\/\/doi.org\/10.1172\/JCI137244.","journal-title":"J Clin Invest."},{"issue":"3","key":"9283_CR35","doi-asserted-by":"publisher","first-page":"ofw171","DOI":"10.1093\/ofid\/ofw171","volume":"3","author":"NF Crum-Cianflone","year":"2016","unstructured":"Crum-Cianflone NF. Invasive Aspergillosis Associated With Severe Influenza Infections. Open Forum Infect Dis. 2016;3(3):ofw171. https:\/\/doi.org\/10.1093\/ofid\/ofw171.","journal-title":"Open Forum Infect Dis."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09283-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09283-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T11:02:46Z","timestamp":1712833366000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09283-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9283"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09283-3","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,11]]},"assertion":[{"value":"14 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki. The study was approved by the local Ethics Committee of Azienda Ospedaliera Universitaria Policlinico Umberto I, Rome (ID Prot. 109\/2020). The need for written informed consent was waived by the local Ethics Committee of Azienda Ospedaliera Universitaria Policlinico Umberto I due to retrospective nature of the study. However, at hospital admission, all the patients provided general consent for the use of their clinical data in future studies.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"392"}}